Shares of Hims & Hers were on fire Monday because the FDA's new leader seems to be a fan of the company's business model.

Hims & Hers Health Inc. shares surged 24% to close at fresh record after Hunterbrook Media said the company is poised to be a ...

Cassava Sciences ( SAVA) stock dropped 87% on Monday to close the day’s trading at $4.29 a shares. Cassava is a biotechnology ...

Looking for a solution for hair loss can feel like a huge undertaking. With the overwhelming number of brands to choose from ...

Shares of Hims & Hers are moving higher after President-elect Donald Trump nominated Dr. Marty Makary, a pancreatic surgeon at Johns ...

On Friday, Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $25.33 which represents a slight increase of $1.18 or 4.89% from the prior close of $24.15. The stock opened at ...

Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different ...

Should you invest $1,000 in Hims & Hers Health right now? Before you buy stock in Hims & Hers Health, consider this: The ...

Schrödinger is an unusual animal in the AI in drug discovery landscape. In a new interview with CEO Ramy Farid, STAT’s ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Hims & Hers' financials are robust, with strong and accelerating revenue growth, growing free cash flow, manageable SBC, and ...